Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?

Authors : Klastersky J, Awada A
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pages : 17-23